Trial intelligence / Profile preview

Liraglutide for perioperative glucose control and coagulation in elective hip surgery

NL-OMON26959Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Aug 2012
Modality
Peptides
Countries
1
01

Overview

Randomised trial of liraglutide in hyperglycemia (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in mean glucose at postoperative day 3. Started Aug 2012; status: active, not recruiting.

02

Drugs

03

Conditions

hyperglycemia

Beyond the preview

Go deeper on NL-OMON26959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call